Literature DB >> 9772296

Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.

Y Adachi1, F Itoh, H Yamamoto, K Matsuno, Y Arimura, M Kusano, T Endoh, Y Hinoda, M Oohara, M Hosokawa, K Imai.   

Abstract

Matrilysin is one of matrix metalloproteinases, which is supposed to have a specific role in tumor progression. Expression of matrilysin was investigated in gastric and esophageal cancers by an immunohistochemical examination. Matrilysin was expressed in all esophageal squamous cell carcinomas (13/13) and in the majority of gastric adenocarcinomas (31/35, 89%). The positive staining was observed in tumor cells of cancerous tissues. In gastric cancers, there were significant statistical correlations between matrilysin expression at the invasive front and nodal metastasis or advanced stage. These results suggest that overexpression of matrilysin has an important role in the progression of upper gastrointestinal cancers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9772296     DOI: 10.3892/ijo.13.5.1031

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  25 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells.

Authors:  Guogang Yuan; Lu Qian; Lun Song; Ming Shi; Dan Li; Ming Yu; Meiru Hu; Beifen Shen; Ning Guo
Journal:  Mol Cell Biochem       Date:  2008-07-04       Impact factor: 3.396

Review 3.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

4.  MMP-7 as a prognostic marker in colorectal cancer.

Authors:  Selja Koskensalo; Johanna Louhimo; Stig Nordling; Jaana Hagström; Caj Haglund
Journal:  Tumour Biol       Date:  2010-08-28

Review 5.  Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy.

Authors:  Domenico Viterbo; Valerie Gausman; Tamas Gonda
Journal:  World J Gastrointest Endosc       Date:  2016-02-10

Review 6.  Helicobacter pylori and gastric cancer: factors that modulate disease risk.

Authors:  Lydia E Wroblewski; Richard M Peek; Keith T Wilson
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.

Authors:  J R Bebb; D P Letley; R J Thomas; F Aviles; H M Collins; S A Watson; N M Hand; A Zaitoun; J C Atherton
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

8.  Enhanced cell surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma.

Authors:  Shohei Koyama
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

9.  Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas.

Authors:  Tadahiko Masaki; Masanori Sugiyama; Hiroyoshi Matsuoka; Nobutsugu Abe; Yumi Izumisato; Atsuhiko Sakamoto; Yutaka Atomi
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 10.  In vivo cancer biomarkers of esophageal neoplasia.

Authors:  Shaoying Lu; Thomas D Wang
Journal:  Cancer Biomark       Date:  2008       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.